Salient Surgical Technologies, a developer and marketer of energy devices for use in surgical procedures, has filed a lawsuit in the US District Court for the District of Delaware against Bovie Medical for patent infringement.
Salient Surgical said that the complaint charges that Bovie’s manufacture, use, and sale of the Saline Enhanced Electrosurgical Resection (SEER) device infringes US Patent No. 7,364,579, titled ‘Fluid-assisted Electrosurgical Device’ (the ‘579 Patent).
Salient Surgical has licensed the ‘579 Patent from Medtronic, which is also a plaintiff in the case.
Salient Surgical is a medical technology company that develops and markets advanced energy devices for use in surgical procedures. Salient’s proprietary Transcollation technology allows surgeons to treat tissue at the surgical site by transforming specific types of collagen-based structures to improve patient outcomes.
Salient Surgical’s products are currently used in orthopedic reconstruction and trauma, reconstruction, spine surgery and surgical oncology.